当前位置: 首页 >> 检索结果
共有 10420 条符合本次的查询结果, 用时 5.4173855 秒

7501. Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab.

作者: A Marchesoni.;M Arreghini.;B Panni.;N Battafarano.;L Uziel.
来源: Rheumatology (Oxford). 2003年42卷1期193-4页

7502. Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan.

作者: M Humbert.;J Cabane.
来源: Rheumatology (Oxford). 2003年42卷1期191-3页

7503. Use of patient age and anti-Ro/La antibody status to determine the probability of patients with systemic lupus erythematosus and sicca symptoms fulfilling criteria for secondary Sjögren's syndrome.

作者: A Prabu.;T Marshall.;C Gordon.;T Plant.;A Bawendi.;S Heaton.;S Jobson.;D Briggs.;S J Bowman.
来源: Rheumatology (Oxford). 2003年42卷1期189-91页

7504. Tumour necrosis factor inhibitors: maximizing patient safety.

作者: A P Cairns.;A J Taggart.
来源: Rheumatology (Oxford). 2003年42卷1期188-9页

7505. A rare but important cause for a raised serum creatine kinase concentration: two case reports and a literature review.

作者: B Galarraga.;D Sinclair.;M N Fahie-Wilson.;F C McCrae.;R G Hull.;J M Ledingham.
来源: Rheumatology (Oxford). 2003年42卷1期186-8页

7506. Adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome.

作者: J H Raphael.;J L Southall.;G D Kitas.
来源: Rheumatology (Oxford). 2003年42卷1期185-6页

7507. Two cases of atopic dermatitis associated with autoimmune abnormalities.

作者: I Sekigawa.;T Yoshiike.;N Iida.;H Hashimoto.;H Ogawa.
来源: Rheumatology (Oxford). 2003年42卷1期184-5页

7508. The first descriptions of therapeutic arthrocentesis: a historical note.

作者: F J Aceves-Avila.;M A Delgadillo-Ruano.;C Ramos-Remus.;A Gómez-Vargas.;S Gutiérrez-Ureña.
来源: Rheumatology (Oxford). 2003年42卷1期180-3页
The existence of synovial fluid has been known since Hippocratic times. The abnormal accumulation of liquid inside the joints has been recognized as the proximal cause of rheumatic diseases since humoral theory was the dominant paradigm in Occidental medical culture. Although evacuating the excess of the abnormal humour was the target of all therapeutic measures taken during this era, no mention of arthrocentesis is found in Occidental medical texts until 1652. We present two earlier indications of arthrocentesis to treat abnormal accumulation of liquid inside the joints. One in the Codex Badianus, an Aztec manuscript written in the 16th century, and the other in the Tractado breve de medicina, published in Mexico in 1592.

7509. Changes in rheumatology out-patient workload over 12 years in the South West of England.

作者: J R Kirwan.;H Averns.;P Creamer.;M Davies.;P Hickling.;C Hutton.;R Jacoby.;V Kyle.;C Laversuch.;T Palferman.;J Tobias.;N Viner.;A Woolf.;D Yates.
来源: Rheumatology (Oxford). 2003年42卷1期175-9页

7510. Non-inherited maternal HLA alleles are associated with rheumatoid arthritis.

作者: S Harney.;J Newton.;A Milicic.;M A Brown.;B P Wordsworth.
来源: Rheumatology (Oxford). 2003年42卷1期171-4页
Rheumatoid arthritis (RA) is strongly associated with a series of HLA-DRB1 alleles that encode a conserved sequence of amino acids ((70)Q/R K/R R A A(74)) in the DRbeta1 chain, known as the shared epitope (SE). However 30% of patients are negative for DRB1*04 and 15% are SE-negative. Exposure to these alleles as non-inherited maternal antigens (NIMA) might explain this discrepancy. We undertook a family study to investigate the role of NIMA in RA.

7511. Younger age of onset of gout in Taiwan.

作者: K-H Yu.;S-F Luo.
来源: Rheumatology (Oxford). 2003年42卷1期166-70页
To study the clinical features of gout in the community and in medical centres, and to describe the recent changes in gout in Chinese patients.

7512. Embryonic stem cells injected into the mouse knee joint form teratomas and subsequently destroy the joint.

作者: S Wakitani.;K Takaoka.;T Hattori.;N Miyazawa.;T Iwanaga.;S Takeda.;T K Watanabe.;A Tanigami.
来源: Rheumatology (Oxford). 2003年42卷1期162-5页
To determine whether the joint space is a suitable environment for embryonic stem (ES) cells to grow and form cartilage.

7513. Autoantibodies to dsDNA cross-react with the arginine-glycine-rich domain of heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) and promote methylation of hnRNP A2.

作者: K-H Sun.;S-J Tang.;Y-S Wang.;W-J Lin.;R-I You.
来源: Rheumatology (Oxford). 2003年42卷1期154-61页
This study was designed to clarify the internalization of anti-DNA antibodies (anti-DNA) into living cells in the pathogenesis of systemic lupus erythematosus (SLE) using anti-DNA monoclonal antibodies (mAbs).

7514. Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations.

作者: K MacKay.;A Milicic.;D Lee.;M Tikly.;S Laval.;J Shatford.;P Wordsworth.
来源: Rheumatology (Oxford). 2003年42卷1期149-53页
IL-10 is an immunoregulatory cytokine which may modulate disease expression in rheumatoid arthritis (RA). The IL-10 gene is highly polymorphic with a number of single nucleotide polymorphisms in the promoter region and two microsatellite loci, IL10.R and IL10.G, 4 kb and 1.1 kb 5' of the transcription initiation site. It has been reported that allele 2 of the IL10.R microsatellite (IL10.R2) is associated with increased IL-10 secretion and IL10.R3 with reduced secretion. Subsequently, over-representation of IL10.R2 and under-representation of IL10.R3 in three independent RA groups has been reported. The aim of the current study is to determine whether there is an association between the IL10.R2 allele and RA in two ethnically distinct populations.

7515. A randomized double-blind pilot study comparing Doloteffin and Vioxx in the treatment of low back pain.

作者: S Chrubasik.;A Model.;A Black.;S Pollak.
来源: Rheumatology (Oxford). 2003年42卷1期141-8页
This randomized, double-dummy, double-blind pilot study of acutely exacerbated low back pain was aimed to inform a definitive comparison between Doloteffin, a proprietary extract of Harpagophytum, and rofecoxib, a selective inhibitor of cyclo-oxygenase-2 (COX-2).

7516. Control perceptions in patients with rheumatoid arthritis: the impact of the medical consultation.

作者: S Ryan.;A Hassell.;P Dawes.;S Kendall.
来源: Rheumatology (Oxford). 2003年42卷1期135-40页
To identify factors that patients perceive as influencing control in living with the symptoms of rheumatoid arthritis (RA).

7517. Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls.

作者: D R Haynes.;E Barg.;T N Crotti.;C Holding.;H Weedon.;G J Atkins.;A Zannetino.;M J Ahern.;M Coleman.;P J Roberts-Thomson.;M Kraan.;P P Tak.;M D Smith.
来源: Rheumatology (Oxford). 2003年42卷1期123-34页
To demonstrate the expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in synovial tissue from rheumatoid arthritis (RA) patients, establish the cell lineage expressing OPG and compare the expression of OPG in RA, spondyloarthropathies, osteoarthritis and normal synovial tissue.

7518. Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus.

作者: C Y Ho.;C K Wong.;E K Li.;L S Tam.;C W K Lam.
来源: Rheumatology (Oxford). 2003年42卷1期117-22页
To investigate the correlations among plasma concentrations of nitric oxide (NO), soluble thrombomodulin (sTM) and vascular cell adhesion molecule (sVCAM-1), and whether these three molecules are associated with renal involvement in patients with systemic lupus erythematosus (SLE).

7519. The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus.

作者: M A López-Nevot.;L Ramal.;J Jiménez-Alonso.;J Martín.
来源: Rheumatology (Oxford). 2003年42卷1期113-6页
There is increasing evidence that nitric oxide (NO) may be important in the pathogenesis of systemic lupus erythematosus (SLE). One possible explanation for the differences observed in NO production between SLE patients and controls is variation in the 5' promoter region of the NOS2 gene, which controls NOS2 transcription. We studied the possible contribution of (CCTTT)(n) microsatellite polymorphism in the NOS2 promoter region to susceptibility to SLE and the clinical outcome of the disease.

7520. Medically unexplained symptoms in patients referred to a specialist rheumatology service: prevalence and associations.

作者: N L Maiden.;N P Hurst.;A Lochhead.;A J Carson.;M Sharpe.
来源: Rheumatology (Oxford). 2003年42卷1期108-12页
To determine the prevalence of medically unexplained rheumatic symptoms amongst patients newly referred to a rheumatology out-patient service and to examine their relationship with pain, disability, socioeconomic factors and the presence of emotional disorders (anxiety, depression and panic).
共有 10420 条符合本次的查询结果, 用时 5.4173855 秒